Health ❯ Healthcare ❯ Drug Development

FDA Approval

Clinical Trials Cancer Therapies Oral Medications New Drug Application Next-Generation Medications Orforglipron AUVELITY Suzetrigine Pivotal Trials Hyperphagia Treatment Targeted Therapy Anktiva Oncology Intravesical Therapy Tecelra Orphan Drug Designation

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

CVS says the change will expand treatment options to lower costs for tens of millions of commercially insured people.

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

‘Dancing Molecules’ Therapy Regenerates Nerves in Advanced Human Spinal Cord Organoids

ImmunityBio Sets 30-Day FDA Submission After Positive Meeting on Anktiva Expansion

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

Arcutis Turns First Profit on Zoryve Surge, Lifts Outlook as Stock Jumps

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma